152 related articles for article (PubMed ID: 16282885)
1. Metronomic therapy: it makes sense and is patient friendly.
Kamen BA
J Pediatr Hematol Oncol; 2005 Nov; 27(11):571-2. PubMed ID: 16282885
[No Abstract] [Full Text] [Related]
2. A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer.
Kieran MW; Turner CD; Rubin JB; Chi SN; Zimmerman MA; Chordas C; Klement G; Laforme A; Gordon A; Thomas A; Neuberg D; Browder T; Folkman J
J Pediatr Hematol Oncol; 2005 Nov; 27(11):573-81. PubMed ID: 16282886
[TBL] [Abstract][Full Text] [Related]
3. [A new treatment protocol targeting tumor vasculature--- metronomic chemotherapy combined radiotherapy].
Qiu H; Wang GM
Ai Zheng; 2007 Dec; 26(12):1392-6. PubMed ID: 18076810
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis inhibitors in combinatorial approaches.
Nowak-Sliwinska P; Griffioen AW
Angiogenesis; 2017 May; 20(2):183-184. PubMed ID: 28382510
[No Abstract] [Full Text] [Related]
5. Targeted therapy: An elusive cancer target.
Brown C
Nature; 2016 Sep; 537(7620):S106-8. PubMed ID: 27626779
[No Abstract] [Full Text] [Related]
6. Metronomic therapy: chemotherapy revisited.
Noronha V; Krishna MV; Patil V; Joshi A; Banavali SD; Prabhash K
Indian J Cancer; 2013; 50(2):142-8. PubMed ID: 23979206
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic strategies and agents in clinical trials.
Rosen L
Oncologist; 2000; 5 Suppl 1():20-7. PubMed ID: 10804087
[TBL] [Abstract][Full Text] [Related]
8. CANCER. Tumor angiogenesis, from foe to friend.
Rivera LB; Bergers G
Science; 2015 Aug; 349(6249):694-5. PubMed ID: 26273044
[No Abstract] [Full Text] [Related]
9. Metronomic chemotherapy for cancer treatment: a decade of clinical studies.
Romiti A; Cox MC; Sarcina I; Di Rocco R; D'Antonio C; Barucca V; Marchetti P
Cancer Chemother Pharmacol; 2013 Jul; 72(1):13-33. PubMed ID: 23475105
[TBL] [Abstract][Full Text] [Related]
10. Anticancer therapy with angiogenesis inhibitors.
Ghilardi C; Bani MR; Giavazzi R
Tumori; 2001; 87(6):S14-6. PubMed ID: 11989610
[No Abstract] [Full Text] [Related]
11. [Inhibition of angiogenesis by proteins, peptides and "small molecules"].
Jayson G; Armand JP; Berdel WE
Onkologie; 2005 Oct; 28 Suppl 4():29-34. PubMed ID: 16205103
[No Abstract] [Full Text] [Related]
12. Angiogenesis. A boost for tumor starvation.
Marx J
Science; 2003 Jul; 301(5632):452-4. PubMed ID: 12881543
[No Abstract] [Full Text] [Related]
13. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
Kerbel RS
Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
[TBL] [Abstract][Full Text] [Related]
14. Metformin and Angiogenesis in Cancer - Revisited.
Kannarkatt J; Alkharabsheh O; Tokala H; Dimitrov NV
Oncology; 2016; 91(4):179-184. PubMed ID: 27487294
[TBL] [Abstract][Full Text] [Related]
15. A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer.
Pietras K; Hanahan D
J Clin Oncol; 2005 Feb; 23(5):939-52. PubMed ID: 15557593
[TBL] [Abstract][Full Text] [Related]
16. The anti-angiogenic basis of metronomic chemotherapy.
Kerbel RS; Kamen BA
Nat Rev Cancer; 2004 Jun; 4(6):423-36. PubMed ID: 15170445
[No Abstract] [Full Text] [Related]
17. Moving beyond anti-vascular endothelial growth factor therapy in ovarian cancer.
Sood AK; Coleman RL; Ellis LM
J Clin Oncol; 2012 Feb; 30(4):345-7. PubMed ID: 22184398
[No Abstract] [Full Text] [Related]
18. Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility.
Close A
Future Med Chem; 2016; 8(4):443-62. PubMed ID: 26933926
[TBL] [Abstract][Full Text] [Related]
19. In focus: non-small cell lung cancer: E1505.
Clin Adv Hematol Oncol; 2007 Mar; 5(3):206-8. PubMed ID: 17519882
[No Abstract] [Full Text] [Related]
20. Angiogenesis pathway inhibitors.
Herbst RS; LoRusso P; Isobe T; Hurwitz HI
Cancer Chemother Biol Response Modif; 2005; 22():225-45. PubMed ID: 16110614
[No Abstract] [Full Text] [Related]
[Next] [New Search]
